News About: Pharm. Industry
BMS Korea appointed Hye-sun Park as its new president
BMS Korea has appointed Hye-sun Park as a new president as of the 1st of September.
President Hye-sun Park will take charge of development and execution of tailored company strategies for BMS Korea, a specialty care ...
‘Cardiovascular and psychotropic’ drugs led the generic market in the first half of 2015
The Ministry of Food and Drug Safety(Minister Seung-hee Kim) announced there were the total 51 cases of result approvals analyzing the current approval condition for bioequivalence tests required to develop generic pr...
The average annual salary per employee of medical device companies was KRW 40.83 million while Samsung Medison ranked the top
The average annual salary employees in domestic medical device companies was early KRW 40 million, and a company paying the most annual salary was Samsung Medison, an ultrasonic imaging device manufacturing company.
...
The average annual salary per employee of medical device companies was KRW 40.83 million while Samsung Medison ranked the top
The average annual salary employees in domestic medical device companies was early KRW 40 million, and a company paying the most annual salary was Samsung Medison, an ultrasonic imaging device manufacturing company.
...
Both pharmaceutical and biopharmaceutical on streak went down together due to earning-shock
Pharmaceutical and biopharmaceutical stocks, which had been on streak until the first half of the year, has encountered a turn. It was analyzed that the phenomenon was started by the opening of their first half’s perf...
Fierce competition is expected in the ‘Nexium Tab’ generic market
Approvals for the ‘esomeprazole magnesium’ drug, an antiulcer drug expired in patent last July, have been significantly increased this year.
This is because domestic pharmaceutical companies have decided to choose ‘d...
Exports of pharmaceutical companies significantly increased in the KOSPI, but decreased in the KOSDAQ
While pharmaceutical companies have focused on exportation to overcome limitation of the domestic market and to become a global pharmaceutical company, exports of KOSPI listed pharmaceutical companies were decreased b...
Lilly stated “There will be no price reduction on Cialis,” focusing its business on urology clinicsWhile about 50 domestic companies are expected to launch Cialis generics on the 4th of September, Lilly owning Cialis announced it would not carry out a policy to cut its drug p...
|
The size of the global clinical trial market is KRW 73.5 trillion while the Korean one is KRW 991.1 billion
It was observed that the size of the global clinical trial market reached KRW 75.5 trillion and the one of the domestic clinical trial market were close to KRW 990 billion.
The Ministry of Health and Welfare, on the ...
Samsung Group has expanded its position in the biosimilar filed, establishing 13 pipelines
Samsung Group has been accelerated in expansion of its biosimilar business.
Samsung has currently shown rapid movements in the biopharmaceutical industry market through ‘Samsung Bioepis,’ a biopharmaceutical developm...
